Percutaneous coronary intervention with stenting has become the most widely performed procedure for the treatment of obstructive coronary artery disease. But, a major drawback of coronary stenting is the occurrence of stent thrombosis. Though rare, stent thrombosis can lead to ST segment elevation myocardial infarction or even sudden cardiac death. This is a case of early coronary stent thrombosis in a 58-year-old male patient, who presented with acute chest pain, Mobitz type II 2:1atrioventricular block and cardiogenic shock 15 days after percutaneous coronary intervention with bare metal stenting to the right coronary artery.
INTRODUCTION
Percutaneous coronary intervention (PCI) with stenting with bare metal stent (BMS) or drug eluting stent (DES) has become the most widely performed procedure for the treatment of obstructive coronary artery disease. Stent implantation leads to activation of the coagulation cascade which may lead to stent thrombosis (ST). 1 Though rare, the consequences of ST can be fatal, as most ST cases are associated with myocardial infarction or sud-den death. 2 ST can be divided into early ST (0 to 30 days), late ST (31days to 1 year), and very late ST (>1 year). 3 In case of BMS, complete stent endothelization usually occurs after one month. After this period it is very uncommon to encounter ST in BMS. Early ST may be related to non-adherence to antiplatelet agents, residual target lesion thrombus or dissection, stasis, stent underexpansion, or a combination of these.
In this paper, a case of early ST that occurred after 15 days following BMS implantation is reported.
CASE REPORT
A 58-year-old man with a history of hypertension and present smoker presented to our emergency department with a complaint of acute central chest pain for three hour duration which was associated with nausea and 2 episodes of vomiting. He also had one episode of sudden loss of consciousness. On presentation, he was conscious. His blood pressure (BP) was 80/50 mmHg and pulse rate of 40 bpm. In our patient, the time to the acute thrombotic event from the index PCI was 15 days. Since he was not on dual antiplatelet therapy, we could assume that non-adherence to the antiplatelet agents could be the most important predictor for ST in our patient.
Another potential explanation for this acute event in our patient is the possibility of stent malapposition. It has been reported that the most common cause of early bare-metal ST is stent malapposition. 10 This can be attributed to dissection at the edges of the stent or stent deployment issues such as incomplete expansion and apposition.
However, since intravascular ultrasound was not performed because of its unavailability in our center, this suspicion could not be confirmed.
Another possibility for early ST could be impaired response to antiplatelet therapy.
In conclusion, early ST with the use of BMS, although fortunately infrequent, is a catastrophic event. Avoidance of stent undersizing by the operator, regular use of higher balloon pressures during stent implantation and strict adherence to dual antiplatelet treatment are crucial to minimize this complication.
